Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2017 2
2018 1
2021 1
2022 2
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Homologous Recombination Deficiency: Concepts, Definitions, and Assays.
Stewart MD, Merino Vega D, Arend RC, Baden JF, Barbash O, Beaubier N, Collins G, French T, Ghahramani N, Hinson P, Jelinic P, Marton MJ, McGregor K, Parsons J, Ramamurthy L, Sausen M, Sokol ES, Stenzinger A, Stires H, Timms KM, Turco D, Wang I, Williams JA, Wong-Ho E, Allen J. Stewart MD, et al. Among authors: stires h. Oncologist. 2022 Mar 11;27(3):167-174. doi: 10.1093/oncolo/oyab053. Oncologist. 2022. PMID: 35274707 Free PMC article.
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.
Olukoya AO, Stires H, Bahnassy S, Persaud S, Guerra Y, Ranjit S, Ma S, Cruz MI, Benitez C, Rozeboom AM, Ceuleers H, Berry DL, Jacobsen BM, Raj GV, Riggins RB. Olukoya AO, et al. Among authors: stires h. J Endocr Soc. 2023 Sep 15;7(10):bvad117. doi: 10.1210/jendso/bvad117. eCollection 2023 Aug 28. J Endocr Soc. 2023. PMID: 37766843 Free PMC article.
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer.
Bahnassy S, Stires H, Jin L, Tam S, Mobin D, Balachandran M, Podar M, McCoy MD, Beckman RA, Riggins RB. Bahnassy S, et al. Among authors: stires h. bioRxiv [Preprint]. 2023 Aug 22:2023.08.21.554116. doi: 10.1101/2023.08.21.554116. bioRxiv. 2023. PMID: 37662291 Free PMC article. Updated. Preprint.
ROS is a master regulator of in vitro matriptase activation.
Gaymon DO, Barndt R, Stires H, Riggins RB, Johnson MD. Gaymon DO, et al. Among authors: stires h. PLoS One. 2023 Jan 30;18(1):e0267492. doi: 10.1371/journal.pone.0267492. eCollection 2023. PLoS One. 2023. PMID: 36716335 Free PMC article.
A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets.
McKelvey BA, Berk A, Chin L, Hudgens S, Kudel I, O'Hagan RC, Patel A, Scott J, Stires H, Wang S, Wujcik D, Stewart M, Allen J. McKelvey BA, et al. Among authors: stires h. JCO Clin Cancer Inform. 2023 Feb;7:e2200161. doi: 10.1200/CCI.22.00161. JCO Clin Cancer Inform. 2023. PMID: 36821804 Free article.
16 results